Joan Greffrath’s positive attitude explains why she considers it “a gift” to participate in a clinical trial for breast reconstruction after mastectomy.

UMMS has joined the BioPontis Alliance to identify innovative biomedical breakthroughs that have the potential to become viable treatments.

A team of scientists, including faculty at UMMS, have discovered a gene that influences survival time in ALS.

Reflectance Medical Inc., founded by Babs Soller, PhD, has received FDA clearance for a non-invasive monitor of muscle tissue oxygen levels.

The UMass Center for Clinical and Translational Science awarded UMass Life Sciences Moment Fund grants to four teams of investigators from UMMS and other campuses.

The UMass Center for Clinical and Translational Science has named David McManus, MD, the 2012 Clinical Research Scholar and awarded three Pilot Project Program Awards.

A new genetic mutation that causes familial ALS has been identified by a team of scientists led by researchers at UMMS.

Brian P. O’Sullivan, MD, has been named the director of the newly established Bioethics Core.